Alopecia areata treatment with baricitinib: different relapse phenotypes

被引:1
作者
Micali, Giuseppe [1 ]
Dall'Oglio, Federica [1 ]
Nasca, Maria Rita [1 ]
Lacarrubba, Francesco [1 ]
Vitale, Pasquale [1 ]
机构
[1] Univ Catania, Dermatol Clin, Catania, Italy
关键词
D O I
10.1080/09546634.2024.2324832
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页数:2
相关论文
共 3 条
[1]   Complete response of extensive alopecia areata refractory to baricitinib after five months of treatment with upadacitinib [J].
De la Torre-gomar, Francisco Javier ;
Velasco-Amador, Juan Pablo ;
Prados-Carmona, Alvaro ;
Ruiz-Villaverde, Ricardo .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
[2]   Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2) [J].
Kwon, Ohsang ;
Senna, Maryanne. M. M. ;
Sinclair, Rodney ;
Ito, Taisuke ;
Dutronc, Yves ;
Lin, Chen-Yen ;
Yu, Guanglei ;
Chiasserini, Chiara ;
McCollam, Jill ;
Wu, Wen-Shuo ;
King, Brett .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (03) :443-451
[3]   The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies [J].
Yan, Diqin ;
Fan, Huaying ;
Chen, Min ;
Xia, Lin ;
Wang, Simin ;
Dong, Wenliang ;
Wang, Qian ;
Niu, Suping ;
Rao, Huiying ;
Chen, Liming ;
Nie, Xiaoyan ;
Fang, Yi .
FRONTIERS IN PHARMACOLOGY, 2022, 13